nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprazolam—GABRB2—GABA receptor activation—KCNJ5—adrenal gland cancer	0.0438	0.0459	CbGpPWpGaD
Alprazolam—GABRA5—GABA receptor activation—KCNJ5—adrenal gland cancer	0.0426	0.0446	CbGpPWpGaD
Alprazolam—GABRA3—GABA receptor activation—KCNJ5—adrenal gland cancer	0.0418	0.0438	CbGpPWpGaD
Alprazolam—GABRA2—GABA receptor activation—KCNJ5—adrenal gland cancer	0.0411	0.043	CbGpPWpGaD
Alprazolam—GABRB3—GABA receptor activation—KCNJ5—adrenal gland cancer	0.0408	0.0427	CbGpPWpGaD
Alprazolam—GABRG2—GABA receptor activation—KCNJ5—adrenal gland cancer	0.0401	0.042	CbGpPWpGaD
Alprazolam—GABRA1—GABA receptor activation—KCNJ5—adrenal gland cancer	0.035	0.0367	CbGpPWpGaD
Alprazolam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ5—adrenal gland cancer	0.0202	0.0211	CbGpPWpGaD
Alprazolam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ5—adrenal gland cancer	0.0196	0.0205	CbGpPWpGaD
Alprazolam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ5—adrenal gland cancer	0.0192	0.0201	CbGpPWpGaD
Alprazolam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ5—adrenal gland cancer	0.0189	0.0198	CbGpPWpGaD
Alprazolam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ5—adrenal gland cancer	0.0188	0.0196	CbGpPWpGaD
Alprazolam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ5—adrenal gland cancer	0.0184	0.0193	CbGpPWpGaD
Alprazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ5—adrenal gland cancer	0.0161	0.0169	CbGpPWpGaD
Alprazolam—GABRB2—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.0151	0.0159	CbGpPWpGaD
Alprazolam—CYP3A4—Codeine and Morphine Metabolism—ABCB1—adrenal gland cancer	0.015	0.0157	CbGpPWpGaD
Alprazolam—GABRA5—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.0147	0.0154	CbGpPWpGaD
Alprazolam—GABRA3—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.0145	0.0151	CbGpPWpGaD
Alprazolam—GABRA2—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.0142	0.0149	CbGpPWpGaD
Alprazolam—GABRB3—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.0141	0.0148	CbGpPWpGaD
Alprazolam—GABRG2—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.0139	0.0145	CbGpPWpGaD
Alprazolam—GABRA1—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.0121	0.0127	CbGpPWpGaD
Alprazolam—Ketazolam—ABCB1—adrenal gland cancer	0.012	0.27	CrCbGaD
Alprazolam—GABRB2—Neuronal System—KCNJ5—adrenal gland cancer	0.0116	0.0121	CbGpPWpGaD
Alprazolam—GABRA5—Neuronal System—KCNJ5—adrenal gland cancer	0.0113	0.0118	CbGpPWpGaD
Alprazolam—GABRA3—Neuronal System—KCNJ5—adrenal gland cancer	0.0111	0.0116	CbGpPWpGaD
Alprazolam—GABRA2—Neuronal System—KCNJ5—adrenal gland cancer	0.0109	0.0114	CbGpPWpGaD
Alprazolam—GABRB3—Neuronal System—KCNJ5—adrenal gland cancer	0.0108	0.0113	CbGpPWpGaD
Alprazolam—CYP3A5—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.0106	0.0111	CbGpPWpGaD
Alprazolam—GABRG2—Neuronal System—KCNJ5—adrenal gland cancer	0.0106	0.0111	CbGpPWpGaD
Alprazolam—GABRA1—Neuronal System—KCNJ5—adrenal gland cancer	0.00928	0.00971	CbGpPWpGaD
Alprazolam—Clobazam—ABCB1—adrenal gland cancer	0.00849	0.191	CrCbGaD
Alprazolam—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—adrenal gland cancer	0.0082	0.00858	CbGpPWpGaD
Alprazolam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.00772	0.00808	CbGpPWpGaD
Alprazolam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.0075	0.00785	CbGpPWpGaD
Alprazolam—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.00749	0.00784	CbGpPWpGaD
Alprazolam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.00737	0.00771	CbGpPWpGaD
Alprazolam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.00724	0.00758	CbGpPWpGaD
Alprazolam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.00719	0.00753	CbGpPWpGaD
Alprazolam—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.00714	0.00747	CbGpPWpGaD
Alprazolam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.00706	0.00739	CbGpPWpGaD
Alprazolam—Nitrazepam—ABCB1—adrenal gland cancer	0.00702	0.158	CrCbGaD
Alprazolam—Flurazepam—ABCB1—adrenal gland cancer	0.00624	0.14	CrCbGaD
Alprazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.00617	0.00646	CbGpPWpGaD
Alprazolam—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.0061	0.00639	CbGpPWpGaD
Alprazolam—GABRB3—BDNF signaling pathway—CDC42—adrenal gland cancer	0.00597	0.00624	CbGpPWpGaD
Alprazolam—GABRB2—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00581	0.00608	CbGpPWpGaD
Alprazolam—Midazolam—ABCB1—adrenal gland cancer	0.00578	0.13	CrCbGaD
Alprazolam—GABRA1—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.00566	0.00593	CbGpPWpGaD
Alprazolam—GABRA5—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00564	0.0059	CbGpPWpGaD
Alprazolam—GABRA3—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00554	0.0058	CbGpPWpGaD
Alprazolam—GABRA2—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00544	0.0057	CbGpPWpGaD
Alprazolam—GABRB3—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00541	0.00566	CbGpPWpGaD
Alprazolam—GABRG2—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00531	0.00556	CbGpPWpGaD
Alprazolam—Diazepam—ABCB1—adrenal gland cancer	0.00496	0.111	CrCbGaD
Alprazolam—CYP3A7—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00495	0.00518	CbGpPWpGaD
Alprazolam—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.00494	0.00517	CbGpPWpGaD
Alprazolam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.00471	0.00493	CbGpPWpGaD
Alprazolam—GABRA1—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00464	0.00486	CbGpPWpGaD
Alprazolam—GABRB2—Neuronal System—PRKACA—adrenal gland cancer	0.00445	0.00466	CbGpPWpGaD
Alprazolam—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00441	0.00462	CbGpPWpGaD
Alprazolam—GABRA5—Neuronal System—PRKACA—adrenal gland cancer	0.00432	0.00452	CbGpPWpGaD
Alprazolam—GABRA3—Neuronal System—PRKACA—adrenal gland cancer	0.00424	0.00444	CbGpPWpGaD
Alprazolam—GABRA2—Neuronal System—PRKACA—adrenal gland cancer	0.00417	0.00436	CbGpPWpGaD
Alprazolam—GABRB3—BDNF signaling pathway—BAD—adrenal gland cancer	0.00416	0.00436	CbGpPWpGaD
Alprazolam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00416	0.00436	CbGpPWpGaD
Alprazolam—GABRB3—Neuronal System—PRKACA—adrenal gland cancer	0.00414	0.00434	CbGpPWpGaD
Alprazolam—GABRG2—Neuronal System—PRKACA—adrenal gland cancer	0.00407	0.00426	CbGpPWpGaD
Alprazolam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00404	0.00423	CbGpPWpGaD
Alprazolam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00397	0.00415	CbGpPWpGaD
Alprazolam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.0039	0.00408	CbGpPWpGaD
Alprazolam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00388	0.00406	CbGpPWpGaD
Alprazolam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00381	0.00398	CbGpPWpGaD
Alprazolam—CYP3A5—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00358	0.00374	CbGpPWpGaD
Alprazolam—GABRA1—Neuronal System—PRKACA—adrenal gland cancer	0.00356	0.00372	CbGpPWpGaD
Alprazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00333	0.00348	CbGpPWpGaD
Alprazolam—GABRB2—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00313	0.00327	CbGpPWpGaD
Alprazolam—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00311	0.00325	CbGpPWpGaD
Alprazolam—GABRA5—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00304	0.00318	CbGpPWpGaD
Alprazolam—GABRA3—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00298	0.00312	CbGpPWpGaD
Alprazolam—GABRA2—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00293	0.00307	CbGpPWpGaD
Alprazolam—GABRB3—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00291	0.00305	CbGpPWpGaD
Alprazolam—CYP2C9—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.00287	0.003	CbGpPWpGaD
Alprazolam—GABRG2—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00286	0.00299	CbGpPWpGaD
Alprazolam—GABRB3—BDNF signaling pathway—CTNNB1—adrenal gland cancer	0.00274	0.00287	CbGpPWpGaD
Alprazolam—CYP3A7—Biological oxidations—POMC—adrenal gland cancer	0.00263	0.00275	CbGpPWpGaD
Alprazolam—CYP2C9—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00252	0.00264	CbGpPWpGaD
Alprazolam—GABRA1—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.0025	0.00262	CbGpPWpGaD
Alprazolam—GABRB2—Neuronal System—BRAF—adrenal gland cancer	0.0024	0.00251	CbGpPWpGaD
Alprazolam—GABRB2—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00239	0.0025	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—SDHB—adrenal gland cancer	0.00235	0.00246	CbGpPWpGaD
Alprazolam—GABRA5—Neuronal System—BRAF—adrenal gland cancer	0.00233	0.00244	CbGpPWpGaD
Alprazolam—GABRA5—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00232	0.00243	CbGpPWpGaD
Alprazolam—GABRA3—Neuronal System—BRAF—adrenal gland cancer	0.00229	0.00239	CbGpPWpGaD
Alprazolam—GABRA3—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00228	0.00239	CbGpPWpGaD
Alprazolam—GABRA2—Neuronal System—BRAF—adrenal gland cancer	0.00225	0.00235	CbGpPWpGaD
Alprazolam—GABRA2—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00224	0.00235	CbGpPWpGaD
Alprazolam—GABRB3—Neuronal System—BRAF—adrenal gland cancer	0.00223	0.00234	CbGpPWpGaD
Alprazolam—GABRB3—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00223	0.00233	CbGpPWpGaD
Alprazolam—GABRA1—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.00221	0.00231	CbGpPWpGaD
Alprazolam—GABRG2—Neuronal System—BRAF—adrenal gland cancer	0.00219	0.00229	CbGpPWpGaD
Alprazolam—GABRG2—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00219	0.00229	CbGpPWpGaD
Alprazolam—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00205	0.00215	CbGpPWpGaD
Alprazolam—GABRB2—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.00194	0.00203	CbGpPWpGaD
Alprazolam—GABRA1—Neuronal System—BRAF—adrenal gland cancer	0.00192	0.00201	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00191	0.002	CbGpPWpGaD
Alprazolam—GABRB2—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.0019	0.00199	CbGpPWpGaD
Alprazolam—CYP3A5—Biological oxidations—POMC—adrenal gland cancer	0.0019	0.00199	CbGpPWpGaD
Alprazolam—GABRA5—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.00188	0.00197	CbGpPWpGaD
Alprazolam—GABRA3—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.00185	0.00194	CbGpPWpGaD
Alprazolam—GABRA5—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.00185	0.00193	CbGpPWpGaD
Alprazolam—GABRA2—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.00182	0.0019	CbGpPWpGaD
Alprazolam—GABRA3—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.00181	0.0019	CbGpPWpGaD
Alprazolam—GABRB3—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.00181	0.00189	CbGpPWpGaD
Alprazolam—GABRA2—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.00178	0.00187	CbGpPWpGaD
Alprazolam—GABRG2—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.00177	0.00186	CbGpPWpGaD
Alprazolam—GABRB3—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.00177	0.00185	CbGpPWpGaD
Alprazolam—GABRG2—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.00174	0.00182	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—SDHB—adrenal gland cancer	0.0017	0.00178	CbGpPWpGaD
Alprazolam—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00166	0.00174	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.00155	0.00162	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.00152	0.00159	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—SDHD—adrenal gland cancer	0.00151	0.00158	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—RRM1—adrenal gland cancer	0.00151	0.00158	CbGpPWpGaD
Alprazolam—CYP2C9—Biological oxidations—POMC—adrenal gland cancer	0.00134	0.0014	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.00129	0.00135	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—SDHB—adrenal gland cancer	0.0012	0.00125	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—MED12—adrenal gland cancer	0.00113	0.00118	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—RRM1—adrenal gland cancer	0.00109	0.00115	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—SDHD—adrenal gland cancer	0.00109	0.00115	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000942	0.000986	CbGpPWpGaD
Alprazolam—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	0.000883	0.000924	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PRKACA—adrenal gland cancer	0.000823	0.000862	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—MED12—adrenal gland cancer	0.000816	0.000854	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—SDHB—adrenal gland cancer	0.00079	0.000826	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—RRM1—adrenal gland cancer	0.000771	0.000807	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—SDHD—adrenal gland cancer	0.000771	0.000807	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—GNAS—adrenal gland cancer	0.000667	0.000698	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—ABCB1—adrenal gland cancer	0.000655	0.000685	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PRKACA—adrenal gland cancer	0.000595	0.000623	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—MED12—adrenal gland cancer	0.000575	0.000602	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000514	0.000538	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—RRM1—adrenal gland cancer	0.000509	0.000532	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—SDHD—adrenal gland cancer	0.000509	0.000532	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—GNAS—adrenal gland cancer	0.000482	0.000505	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—ABCB1—adrenal gland cancer	0.000473	0.000495	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—POMC—adrenal gland cancer	0.000449	0.00047	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PRKACA—adrenal gland cancer	0.00042	0.000439	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.00041	0.000429	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—MED12—adrenal gland cancer	0.000379	0.000397	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PTGS2—adrenal gland cancer	0.000358	0.000375	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GNAS—adrenal gland cancer	0.00034	0.000356	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—ABCB1—adrenal gland cancer	0.000334	0.000349	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—POMC—adrenal gland cancer	0.000325	0.00034	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	0.000277	0.00029	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PTGS2—adrenal gland cancer	0.000259	0.000271	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—POMC—adrenal gland cancer	0.000229	0.00024	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GNAS—adrenal gland cancer	0.000224	0.000235	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	0.00022	0.00023	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PTGS2—adrenal gland cancer	0.000183	0.000191	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—POMC—adrenal gland cancer	0.000151	0.000158	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	0.00012	0.000126	CbGpPWpGaD
